Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

[1]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[2]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[3]  Keming Yu,et al.  Bayesian Mode Regression , 2012, 1208.0579.

[4]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[5]  R. Kronmal,et al.  Comparison of factors associated with carotid intima-media thickness in the Multi-ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[7]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[8]  A. Hofman,et al.  Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification , 2012, Annals of Internal Medicine.

[9]  M. Woodward,et al.  Risk prediction models: II. External validation, model updating, and impact assessment , 2012, Heart.

[10]  M. Woodward,et al.  Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker , 2012, Heart.

[11]  K G M Moons,et al.  Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review , 2011, Heart.

[12]  Michael J Pencina,et al.  Common Carotid Artery Intima-Media Thickness Progression as a Predictor of Stroke in Multi-Ethnic Study of Atherosclerosis , 2011, Stroke.

[13]  D. van der A,et al.  External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes , 2010, Diabetologia.

[14]  V. Aboyans,et al.  The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). , 2010, Journal of the American College of Cardiology.

[15]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[16]  R. Kronmal,et al.  Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness , 2010, AIDS.

[17]  Lukasz Januszkiewicz.  [The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus]. , 2010, Kardiologia polska.

[18]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[19]  R. Ferrari,et al.  Cardiovascular Disease Prevention in Clinical Practice , 2010 .

[20]  N. J. Wareham,et al.  Cardiovascular risk assessment scores for people with diabetes: a systematic review , 2009, Diabetologia.

[21]  Stephen Colagiuri,et al.  Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study , 2009, The Medical journal of Australia.

[22]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[23]  R. Kronmal,et al.  Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) , 2008, European heart journal.

[24]  D. Grönemeyer,et al.  Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. , 2008, Atherosclerosis.

[25]  D. Grönemeyer,et al.  Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. , 2006, Atherosclerosis.

[26]  C. Byrne,et al.  Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[27]  P. Jackson.  Cardiovascular risk assessment , 2005, The Lancet.

[28]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[29]  S. Moebus,et al.  Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf recall study: Identifiability of phone numbers as the major determinant of response , 2005, European Journal of Epidemiology.

[30]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[31]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[32]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[33]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[34]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[35]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[36]  D. Madigan,et al.  Bayesian Model Averaging for Linear Regression Models , 1997 .

[37]  D. Madigan,et al.  Bayesian Model Averaging in Proportional Hazard Models: Assessing the Risk of a Stroke , 1997 .

[38]  Adrian E. Raftery,et al.  ABayesian Model Averaging in Proportional Hazard Models: Assessing Stroke Risk , 1996 .

[39]  A. Raftery.  Bayesian Model Selection in Social Research , 1995 .

[40]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.